and 100 mg and bupivacaine 75 mg were carried out over ten minutes in healthy young adult males. Cardiovascular sequelae were generally trivial at all doses. A collection of subjective central nervous system symptoms were described which may be regarded as early warning of impending local anaesthetic toxicity. Plasma concentrations of etidocaine were proportional to dose and ranged from 2 p,g/ml to 5 p,g/ml at the termination of the infusion.
INTRODUCTION
The quest for better long-acting local anaesthetics has produced two clinically suitable drugs, namely bupivacaine (Marcaine) and etidocaine (Duranest). These are more lipid-soluble analogs of mepivacaine (Carbocaine) and lignocaine (Xylocaine).
In common with all other local anaesthetics these compounds have the potential for producing cardiovascular and CNS effects following absorption from sites of application. The purpose of this study was to compare systemic effects of bupivacaine and etidocaine in man after intravenous (IV) infusions which reproduce plasma levels commonly observed when these drugs are used for peripheral and central nerve blocks (Cousins et al. 1978 , Stanton-Hicks et al. 1976 .
Subjects
Subjects of the study were 14 healthy male volunteers aged 19-37 and of normal body weight to height ratio. Five subjects received 50 mg etidocaine HCl; eight received 75 mg of both bupivacaine HCl and etidocaine HCl in a cross-over study; and four of the latter and one other also received 100 mg etidocaine HCI on a separate occasion.
Experimental
Subjects were fasted overnight and were prepared for study in the morning. This involved the placement of catheters for continuous recording of arterial and central venous blood pressure, serial determination of cardiac output (CO) by dye-dilution, administration of IV fluids and collection of blood samples. Leg and arm blood flows (LBF and ABF) were measured by venous occlusive plethysmography (Bonica et al. 1970). After control measurements the local anaesthetic was infused at a constant rate over ten minutes via a needle placed in the dorsal venous aspect of the hand contralateral to the arm used for measuring blood flow. The infusion was designed to approximate the time course of plasma drug concentrations resulting from major neural blockade procedures (Tucker and Mather 1975) . Cardiovascular measurements were made over a period of two hours.
The response of the subjects to a check-list (Table 1) of the known subjective effects of local anaesthetics (adapted from Scott 1975) 
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was recorded at five and ten minutes after the start of infusion. Spontaneously volunteered comments were noted at other times. Serial arterial blood samples for drug analysis (Mathcr and Tucker 1974) were obtained throughout the study (see Table 2 ). Serial peripheral venous blood samples were also obtained during the bupivacaine-etidocaine cross-over study.
Statistical analysis
The non-parametric sign-rank test (Gindler 1975 ) was used to establish if an individual variable had changed from its preinjection control value. The magnitude of the mean changes from control values variables were evaluated using Student's t test for paired data.
RESULTS

Plasma concentrations
Arterial Control Etidocaine 0 0 95.6 ± 9.7 9.0 ± 3.1 6.4 ± 1.9 59 ± 10 107 ± 18 1245 ± 258 2.06 ± 0.69 1.06 ± 0.28 Bupivacaine 0 0 92.1 ± 10.3 7.0 ± 3.9 6.0 ± 2.0 59 ± 6 100 ± 25 1312 ± 344 1.75 ± 0.62 0.78 ± 0.15 5 Etidocaine 2.69 ± 0.87 95.0 ± 14.9 9.1 ± 2.9 62 ± 4 Bupivacaine 2.78 ± 0.85 100.4 ± 14.2 7.6 ± 4.6 62± 5 10 Etidocaine 3.56 ± 1.28 2.11 ± 0.56 96.6 ± 14.8 9.5 ± 2.8 62 ± 4 Bupivacaine 3.72 ± 1.01
1.90 ± 0.43 106.0 ± 14.4 9.0 ± 4.7 63 ± 5 15 Etidocaine 1.41 ± 0.45 1.15 ± 0.39 99.7 ± 11.9 9.1 ± 2.7 5.8 ± 1.5 61 ± 7 96 ± 24 1420 ± 329 1.15 ± 0.67 0.93 ± 0.17 Bupivacaine 2.15 ± 0.69
1.96 ± 0.50 106.1 ± 18.6 9.4 ± 4.5 5.6 ± 0.9 61 ± 5 89 ± 15 1551 ± 559 1.13 ± 0.45 0.81 ± 0.17 30 Etidocaine 0.66 ± 0.21 0.72 ± 0.30 98.3 ± 12.5 8.2 ± 3.0 6.2 ± 1.0 61 ± 10 104 ± 12 1278 ± 193 1. 
0\ IF, r-00 tr, 0\
O("'~(",l~."'1"\Cr '.c:-:""";""";""':""':"": 
..,r..,r..,rV;V;V;",,,, ""1" +1+1+1 +1+1+1+1+1+1 -0 0\"'1" t-\O("f"',\C -:"":N""':OCOOo\ agents were similar to those following major neural blockade procedures. Verification of this is shown in Figure 1 where plasma concentrations of bupivacaine following the 75 mg intravenous infusion are superimposed on those occurring after intercostal block with 400 mg bupivacaine containing 1: 320,000 adrenaline (Moore et al. 1976 ).
Cardiovascular effects
Changes in the magnitude of cardiovascular variables were small and mostly not significant. Despite this, there were significant differences III the frequency with which changes in a particular direction occurred as a function of dose and of agent. Mean values of the variables are shown in Tables 2, 3 and 4. Beyond onc hour systematic changes in the variables were not observed.
Mean arterial pressure (MAP)
All subjects exhibited a small increase 111 MAP at 15 minutes following start of injection of the various doses of the local anaesthetics (Sign-rank test, p < 0.05). However, only in the case of bupivacaine was the magnitude of the change significant (paired t test, p < 0.05).
Central venous pressure (CVP)
After 100 mg etidocaine and 75 mg bupivacaine there was a small increase in CVP at 15 minutes after the start of injection (p < 0.05). The magnitude of this change with respect to control values was only significant III the case of bupivacaine.
Cardiac Olltput (CO)
A small decrease in CO was observed at 15 minutes following 100 mg etidocaine (p < 0.05) but the magnitude of this change was not significant.
Heart rate (HR)
Significant changes in HR were not observed with any dose.
Stroke volllme (SV)
Etidocaine (50 mg) was associated with small, definite increase in SV at 15 minutes. However, the higher doses of etidocaine and the 75 mg dose of bupivacaine were associated with small decreases in SV at 15 minutes (p < 0.05). The magni tude of these changes was not significant.
Total peripheral resistance (TPR)
Etidocaine ( at 15 minutes (p < 0.05). The magnitude of the change with etidocaine was significant (p < 0.05).
Arm blood flow (ABF)
At 15 minutes ABF had decreased after 75 and 100 mg of etidocaine and after 75 mg of bupivacaine (p < 0.05). The magnitude of the change with bupivacaine was significant (p < 0.05).
Leg blood flow (LBF)
This was unaffected by any of the infusions.
Subjective effects
Subjective effects were not reported by any of the volunteers recelvmg the low dose (50 mg) of etidocaine. Infusion of 75 and 100 mg of etidocaine and 75 mg bupivacaine regularly produced a collection of effects which may be regarded as the early warning signs of impending local anaesthetic toxicity. These effects were numbness of the lips and tongue, a feeling of pressure in the ears, distorted vision, disorientation, light-headedness and heaviness of the eyelids. The signs occurred earlier with the 100 mg dose of etidocaine compared to the 75 mg dose but were associated with similar mean arterial plasma drug concentrations. Principal effects and the associated arterial plasma concentrations of etidocaine and bupivacaine at the 75 mg dose level are shown in Figure 2 . Effects always regressed wil'hin minutes of cessation of the infusion and in no case was treatment or premature cessation of the infusion necessary. Sedation was not apparent and euphoria was observed in only one subject (C in Figure 2) .
The threshold arterial plasma drug concentrations at which symptoms occurred varied between 2.1-5.3 flg/ml for etidocaine and between 2.2-4.2 flg/ml for bupivacaine. One subject (B in Figure 2 ) experienced no effects with either drug. He also had the lowest plasma concentrations for each drug. One additional subject (H in Figure 2 ) had no effects from etidocaine. His peak arterial concentration of bupivacaine was considerably higher than for etidocaine. A WiIcoxon signed-rank test indicated no significant difference between plasma concentration-effect thresholds for the two drugs, although it was our impression that effects regressed more rapidly with etidocaine. Those subjects experiencing a greater number of effects and more intense effects did so with both drugs.
Arterial plasma concentrations at the end of the infusion were generally 25-50% higher than the corresponding venous concentrations. However they had fallen lower than the venous within 15-30 minutes of cessation of infusion.
Arterial concentrations at the end of the infusion were directly proportional to dose infused. DISCUSSION An important finding of the present study is that the cardiovascular effects observed were small and usually clinically insignificant. It should be re-emphasized that the subjects of this study were healthy, unmedicated young volunteers and results should not be extrapolated to the elderly or infirm. However it is notable that the plasma concentrations produced at the end of the infusion, even at the lowest rate, were high and in the range normally considered toxic for these agents (Tucker and Mather 1975) .
Since the execution of these studies, several reports have been published concerning the central nervous system and the cardiovascular system effects of the local anaesthetic agents. Basically our studies have confirmed the general trends of cardiovascular actions reported by J orfeldt et al. ( 1968) for bupivacaine during intravenous infusions which produced blood concentrations between 0.7-3 ",g/m!. Wiklund (1977) infused ctidocainc or bupivacaine at a rate of 2 mg/min for 150 minutes producing arterial plasma concentrations averaging 2.39 ",g/ml of bupivacaine and 1.96 flg/ml of etidocaine. These concentrations were associated with quite definite cardiovascular changes which were more pronounced for bupivacaine than etidocaine. In general, bupivacaine produced an increase in HR, CO, MAP, left ventricular minute work (LVMW), effective hepatic blood flow (EHBF) together with decreased TPR and splanchnic vascular resistance (SpVR). Etidocaine produced increased LVMW, EHBF and reduced SpVR with the remaining cardiovascular parameters remaining unaltered.
Direct comparison of the present study with that of Wiklund ( 1977) is somewhat difficult because of the differences in infusion time taken to reach the indicated plasma concentrations. In the present study, peak concentrations approximately 50% greater than reported in Wiklund's study were reached after ten minutes of infusion compared with 150 minutes. This is likely to produce effects that are more intense although more transitory.
Our observations regarding acute subjective central nervous system effects are similar to those reported by Scott (1975) , who infused bupivacaine and etidocaine at 10 mg/min for a total dose of 125 mg. However two of Scott's subjects were unable to tolerate the entire dose of bupivacaine and had their infusions terminated after the delivery of 80 and 105 mg, respectively. Scott (1975) also observed that on a milligram dose basis etidocaine was better tolerated than bupivacaine. The early warning signs of toxicity for both of these drugs are similar to those reported for lignocaine (Scott 1975) .
Tt might be anticipated that the systemic effects of the agents would be better correlated with drug concentrations in arterial plasma than venous concentrations sampled from the forearm. Although the arterial plasma concentrations reported in Tables 2, 3 and 4 are considerably higher than the venous concentrations reported by Scott (1975) the conclusions are the same. Following a brief infusion, almost identical plasma concentrations of bupivacaine and etidocaine are obtained for equal infusion rates but concentrations of etidocaine die away much faster. The venous concentrations reported in Table 3 for a dose rate of 7.5 mg/min are comparable with t,hose reported by Scott for an infusion rate of 10 mg/min .. Munson et al. (1975) estimated plasma concentration for etidocaine and bupivacaine in Rhesus monkeys. In the monkey the plasma concentrations of etidocaine and bupivacaine producing seizures were the same, being 4.3 (S.O.l.4) and 4.5 (S.0.1.7) ,ug/ml, respectively. Other studies by Malagodi et al. ( 1977) have indicated that the arterial plasma concentrations producing seizure was influenced by the infusion rate, suggesting that appreciable time is required for distribution into vital organs. It would be anticipated that the same plasma concentrations produced by prolonged infusion would cause more profound physiological effects than after a brief infusion. Hence more intense effects were noted by Wiklund (1977) than in the present study.
The present studies were not designed to reproduce an inadvertent intravascular injection but rather to examine the intrinsic effects of the local anaesthetic agents at similar plasma concentrations to those occurring during major neural blockade procedure (Moore et al. 1976; Stanton-Hicks et al. 1976 ). Thus it may be concluded that the effects of the agents themselves, i.e., isolated from the effects caused by the neural blockade, are quite small. The effects of the agents on the peripheral vascular system were unexpected and not previously described. The intrinsic vasoactivity of the local anaesthetic agents has been the subject of many reports (e.g. Blair 1975) .
Local anaesthetics are either vasoconstrictors or vasodilators depending on the resting tone of the vascular bed (Aberg and Dhuner 1972) . The present report also indicates that their activity may also be concentration dependent. There was an increased arm blood flow at the lowest dose of etidocaine whereas decreased blood flow was observed at the two higher doses. These data help to interpret the findings of 10rfeldt et al. (1970) who reported that intra-arterial injection of mepivacaine decreased but that intravenous injection , increased arm blood flow. The main difference between these routes of injection is' the concentration of mepivacaine delivered to the capillary vascular bed, being substantially greater after intra-arterial than after intravenous. It appears that low concentrations may act as vasodilators while higher concentrations cause vasoconstriction.
